Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New MRI dye could reveal how your organs make energy

NCT ID NCT05041166

First seen Feb 21, 2026 · Last updated Jun 21, 2026 · Updated 19 times

Summary

This study tests a special MRI imaging agent called [13C]pyruvate in 50 healthy volunteers. The goal is to see how this substance moves through and is used by healthy organs. Researchers hope to improve MRI image quality and understand normal metabolism, which could help detect diseases in the future.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10065, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Hyperpolarized [13C]pyruvate

What this could lead to

If successful, this could improve MRI imaging quality, helping doctors see how organs use energy in health and disease.

What could go wrong

This is a small, early-phase study in healthy volunteers only. It does not test any treatment, so results may not directly apply to patients.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.